Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Synchronous Metastasized Breast Cancer|Circulating Tumor Cells
Interventions: PROCEDURE: Surgery|PROCEDURE: Surgery on Demand
Sponsor: Austrian Breast & Colorectal Cancer Study Group
Collaborators: Bayer|Amgen|Hoffmann-La Roche|AstraZeneca|Sanofi Aventis GmbH, Austria|Wyeth Lederle Pharma GmbH, Austria|GlaxoSmithKline|Merck Sharp & Dohme LLC|Fond of the Viennese Mayor